Literature review: Pharmacotherapeutic follow-up provided to type 2 diabetic patients seen at community pharmacies

Authors

DOI:

https://doi.org/10.33448/rsd-v10i8.17150

Keywords:

Type 2 diabetes mellitus; Pharmacotherapeutic follow-up; Community Pharmacist.; Type 2 diabetes mellitus; Pharmacotherapeutic follow-up; Community pharmacist.

Abstract

This review aims to present evidence as to the relevance of pharmacotherapeutic monitoring provided to patients with type 2 diabetes mellitus treated in community pharmacies, in addition to knowing the role of community pharmacists in the control of type 2 diabetes and investigating the positive aspects of pharmacotherapeutic monitoring aimed at diabetic patients. This is a literature review carried out by searching for original articles in databases such as Scielo, PubMed and Lilacs. The inclusion criteria were: publications that met the proposal of the theme, complete articles, in portuguese and published from 2010 to 2019. The exclusion criteria were: incomplete studies, which did not meet the objective and theme of the research, in addition to books, dissertations and theses. The articles that made up the review showed that the main doubts of patients with DM were related to the times of administration of the medications. Other findings showed that there was good acceptability of the proposal for pharmacotherapeutic follow-up and that its applicability in private community pharmacies brings several benefits such as greater adherence to treatment, occurring rationally with improved clinical results and establishing a link between pharmacist and user, reaffirming the capacity pharmacist to carry out clinical activities in the private sector. This study made it clear that the practice of pharmaceutical care and good dispensing practices aimed at patients treated in drugstores can be achieved without the need for major structural changes in the establishment and without hiring additional staff.

References

American Diabetes Association. (2013). Standards of Medical Care in Diabetes. Diabetes Care, 36, S11-S66. 10.2337/dc13-S011.

American Diabetes Association. (2015). Standards of medical Care in Diabetes. Diabetes Care, 38, S4. 10.2337/dc15-S003

Bazotte, R. B. (2012). Paciente diabético: Cuidados Farmacêuticos. MedBook.

Brasil. (2011). Conselho Regional de Farmácia do Estado de São Paulo. Fascículo VII - Manejo do tratamento de Pacientes com diabetes, 78 p.

Brasil. (2016). Conselho Federal de Farmácia. Serviços Farmacêuticos Diretamente Destinados ao Paciente, à Família e à Comunidade: Contextualização e Arcabouço Conceitual. Programa de Suporte ao Cuidado Farmacêutico na Atenção à Saúde. 200 p.

Braz, A. L., Ferreira, E. C., Guedes, D. N., Costa, K. V. M. C., Coreia, N. A., Albuquerque, K. L. G. (2017). Atenção farmacêutica em pacientes hipertensos do Hospital Universitário Lauro Wanderley. Revista de Ciências Médicas e Biológicas, 16(1), 45-51.

Feldman, F. G. S. (2011). Avaliação da atenção farmacêutica para pacientes diabéticos. Trabalho de Conclusão de Curso, Fundação Oswaldo Cruz.

Ferreira, V. L. (2014). A importância do seguimento farmacoterapêutico na saúde: uma revisão da literatura. Trabalho de conclusão de curso, Universidade Federal da Paraíba.

International Diabetes Federation. (2017). IDF Diabetes Atlas Eighth Edition. Bruxelas, Bélgica: International Diabetes Federation.

Lakatos, E.M. & Marconi, M.A. (2010). Fundamentos da metodologia científica. Atlas.

Mendes, E. V. (2011). As redes de atenção à saúde. Organização Pan-Americana da Saúde.

Mendes, I., Guedes, S., Guerreiro, J. P., Inês, M., Sousa, A., & Miranda, A. (2016). Autovigilância da doença e qualidade de vida dos doentes diabéticos: estudo observacional em farmácias comunitárias, Revista Portuguesa de Saúde Pública, 34(1):11-19.

Nunes, L. M. N. et al. (2012). Acompanhamento farmacoterapêutico de pacientes diabéticos tipo 2 e fatores de risco associados. Revista Brasileira de Farmácia, 93(2): 196-203.

Oliveira, T. C. A. et al. (2012). Implantação de protocolo de orientação farmacêutica para indivíduos com Diabetes mellitus em farmácia comunitária. Revista Brasileira de Farmácia, 93(3): 379-384.

Pereira, M. G., Prado, N. M. B. L., & Krepsky, P. B. (2017). Resultados de Seguimento Farmacoterapêutico a pacientes hipertensos em farmácia comunitária privada na Bahia. Revista Baiana de Saúde Pública, 41(2).

Silva, E. V., Naves, J. O. S. & Vidal, J. (2008). O papel do farmacêutico comunitário no aconselhamento ao paciente. Farmacoterapêutica, 8(4-5), 2-6.

Obreli-Neto, P. R., Baldoni, A. O. & Guidoni, C. M. (2013). Farmacoterapia: Guia terapêutico de doenças mais prevalentes. Pharmabooks.

World Health Organization. (2016). Global report on diabetes. Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data.

Whalen, K., Finkel, R. & Panavelil, T. A. (2016). Farmacologia ilustrada. Artmed.

Zubioli, A., Silva, M. A. R. C. P. Da, Tasc, R. S., Curi, R. & Bazotte, R. B. (2013). Pharmaceutical consultation as a tool to improve health outcomes for patients with type 2 diabetes. Brazilian Journal of Pharmaceutical Sciences, 49(1).

Downloads

Published

05/07/2021

How to Cite

BARDÁLEZ RIVERA, J. G. .; QUEMEL, G. K. C. .; SILVA, V. M. da .; COSTA, J. G. da .; SILVA, K. R. P. da .; COSTA, J. B. . Literature review: Pharmacotherapeutic follow-up provided to type 2 diabetic patients seen at community pharmacies. Research, Society and Development, [S. l.], v. 10, n. 8, p. e9010817150, 2021. DOI: 10.33448/rsd-v10i8.17150. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/17150. Acesso em: 27 apr. 2024.

Issue

Vol. 10 No. 8

Section

Health Sciences

License

Copyright (c) 2021 Juan Gonzalo Bardález Rivera; Gleicy Kelly China Quemel; Viviane Monteiro da Silva; Jéssica Giselli da Costa; Kezia Rayane Paulino da Silva; Jonatas Borges Costa

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.